Building the First FDA Approved Autonomous AI in Healthcare - Dr. Michael Abramoff and Seth Rainford

Jan 12, 2022

Have you ever had an idea that you just had to make real? No matter what it took… no matter what obstacles were in your way… no matter how many times people told you no… you just couldn’t stop until it existed? Well, this is one of those stories. It begins with an idea in 1988 and leads to the first-ever autonomous AI to be approved by the FDA for diagnosis without physician input.

Dr. Michael Abramoff is a neuroscientist, a practicing physician, and holds a Ph.D. in Artificial Intelligence and Machine Learning. I know… slacker. In 1988, Michael was working on artificial intelligence during his residency and began to think a computer could diagnose diabetic retinopathy. Given the technology available at the time, this idea may have been a bit of a stretch. Still, Michael set out to prove it could be done.

On this episode, we talk with Dr. Michael Abramov and Seth Rainford about the 30-year journey that led to the founding of Digital Diagnostics, and the first-ever FDA-approved Autonomous AI in healthcare. Plus, we explore the challenges they continue to work through as they commercialize their product.

The journey itself is remarkable and each obstacle and resolution will be relevant to any digital health entrepreneur – especially those in AI and diagnostics.

Of our 180 episodes, this is one of my favorite stories so far. It’s fascinating, entertaining, and incredibly useful. I hope you benefit from it as much as I did.

 

Dr. Michael Abramoff, MD, Ph.D. is the Founder and Executive Chairman of Digital Diagnostics

Seth Rainford is the President and COO at Digital Diagnostics

 

For full show notes, links, and resources: https://thehcbiz.com/180-first-fda-approved-autonomous-ai-in-healthcare/